Levitee Labs Inc. (LVTTF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Levitee Labs Inc. (LVTTF) with AI Score 47/100 (Weak). Levitee Labs Inc. operates as a multidisciplinary integrative wellness company, providing alternative medicines and psychedelic therapies. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Levitee Labs Inc. (LVTTF) Healthcare & Pipeline Overview
Levitee Labs Inc. is a Canadian healthcare company focusing on alternative medicines and psychedelic therapies for substance use disorders and chronic pain, operating clinics and pharmacies. It distinguishes itself through integrative wellness services and electronic prescriptions, competing in the specialty drug manufacturing and mental health treatment sectors.
Investment Thesis
Levitee Labs Inc. presents a unique investment opportunity within the evolving landscape of alternative medicine and psychedelic therapies. With a market capitalization of $0.00B and a negative P/E ratio of -0.03, the company is currently not profitable, reflected in its -662.4% profit margin. However, its 39.9% gross margin indicates potential in its core operations. Growth catalysts include the expansion of its clinic network and the increasing acceptance of psychedelic therapies. The company's ability to scale its BlockMD electronic prescription platform and Earth Circle Organics wholesale business could drive revenue growth. Key risks include regulatory hurdles in the psychedelic therapy space and the company's current lack of profitability. Investors should monitor the company's progress in achieving profitability and navigating the regulatory environment.
Based on FMP financials and quantitative analysis
Key Highlights
- Operates five clinics under the Levitee Clinics brand, providing treatments for substance use disorders and chronic pain.
- Maintains three pharmacies in Alberta under the Levitee Pharmacies name, expanding its reach in pharmaceutical services.
- Offers electronic prescriptions in the addiction treatment space through its BlockMD platform, enhancing accessibility and convenience.
- Wholesales supplements and superfoods under the Earth Circle Organics brand, diversifying its revenue streams.
- Gross margin of 39.9% suggests potential for profitability as the company scales its operations and optimizes costs.
Competitors & Peers
Strengths
- Integrated service model combining clinics, pharmacies, and digital platforms.
- Focus on alternative medicines and psychedelic therapies.
- Established brands like Levitee Clinics and Earth Circle Organics.
- Proprietary technology with the BlockMD electronic prescription platform.
Weaknesses
- Currently not profitable, with a negative profit margin.
- Reliance on regulatory approvals for psychedelic therapies.
- Limited market capitalization and liquidity.
- Exposure to competition from larger and more established healthcare providers.
Catalysts
- Upcoming: Expansion of the Levitee Clinics network into new geographic locations by Q4 2026.
- Ongoing: Development and potential regulatory approval of novel psychedelic therapies for mental health conditions.
- Ongoing: Growth of the BlockMD electronic prescription platform through partnerships with other healthcare providers.
- Ongoing: Expansion of the Earth Circle Organics product line and distribution channels.
- Upcoming: Potential strategic partnerships or acquisitions to expand product and service offerings by mid-2027.
Risks
- Potential: Regulatory hurdles and changing regulations in the psychedelic therapy space.
- Ongoing: Competition from established pharmaceutical companies and healthcare providers.
- Potential: Economic downturns affecting consumer spending on alternative therapies.
- Potential: Negative publicity or safety concerns related to psychedelic therapies.
- Ongoing: Limited liquidity and potential price volatility due to trading on the OTC market.
Growth Opportunities
- Expansion of Clinic Network: Levitee Labs has the opportunity to expand its Levitee Clinics network across Canada and potentially into the United States. The market for addiction and mental health treatment is substantial, with increasing demand for integrated and alternative therapies. Each new clinic can contribute significantly to revenue growth, with a timeline of opening 2-3 new clinics per year over the next five years. This expansion can be funded through strategic partnerships and capital raises.
- Growth of BlockMD Platform: The BlockMD electronic prescription platform offers a significant growth opportunity by streamlining addiction treatment prescriptions. The market for electronic prescriptions is growing rapidly, driven by increased efficiency and convenience. Levitee Labs can expand BlockMD by partnering with other clinics and healthcare providers, creating a broader network and increasing its user base. The timeline for this expansion is within the next 3 years, focusing on integrating with existing healthcare systems.
- Development of Psychedelic Therapies: Levitee Labs can capitalize on the growing interest in psychedelic therapies by developing and offering novel treatments for mental health conditions. The market for psychedelic therapies is projected to reach billions of dollars in the coming years, driven by increasing clinical evidence of their effectiveness. Levitee Labs can invest in research and development to create proprietary therapies and establish itself as a leader in this emerging field. This is a longer-term growth opportunity, with a timeline of 5-7 years for regulatory approvals and market entry.
- Strategic Partnerships and Acquisitions: Levitee Labs can pursue strategic partnerships and acquisitions to expand its product and service offerings. Partnering with other healthcare providers, technology companies, and research institutions can accelerate its growth and enhance its competitive position. Acquisitions of complementary businesses can provide access to new markets, technologies, and customer bases. The timeline for these partnerships and acquisitions is ongoing, with a focus on identifying synergistic opportunities.
- Expansion of Earth Circle Organics: The Earth Circle Organics brand offers an opportunity to expand into the growing market for supplements and superfoods. The demand for natural and organic products is increasing, driven by health-conscious consumers. Levitee Labs can expand its product line, distribution channels, and marketing efforts to reach a broader audience. This expansion can be achieved within the next 2-3 years, focusing on online sales and partnerships with retailers.
Opportunities
- Expansion of clinic network across Canada and the United States.
- Growth of the BlockMD platform through partnerships and integrations.
- Development and commercialization of novel psychedelic therapies.
- Strategic partnerships and acquisitions to expand product and service offerings.
Threats
- Regulatory hurdles and changing regulations in the psychedelic therapy space.
- Competition from established pharmaceutical companies and healthcare providers.
- Economic downturns affecting consumer spending on alternative therapies.
- Negative publicity or safety concerns related to psychedelic therapies.
Competitive Advantages
- Integrated Service Model: Combines clinics, pharmacies, and digital platforms for comprehensive care.
- Proprietary Technology: BlockMD platform provides a unique electronic prescription solution.
- Brand Recognition: Established brands like Levitee Clinics and Earth Circle Organics.
- Expertise in Alternative Therapies: Focus on evidence-based alternative medicines and psychedelic therapies.
About LVTTF
Levitee Labs Inc., established in 2019 and based in Vancouver, Canada, is a multidisciplinary integrative wellness company focused on providing evidence-based alternative medicines and novel psychedelic therapies. Originally named Fibonacci Capital Corp., the company rebranded to Levitee Labs Inc. in November 2020 to better reflect its evolving mission. The company operates through two segments: Medical Services and Selling Products. The Medical Services segment includes five Levitee Clinics, offering treatments for substance use disorders, chronic pain (such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome), hepatitis-C, and mental health conditions. The Selling Products segment encompasses three Levitee Pharmacies in Alberta, providing pharmaceutical services and products. Additionally, Levitee Labs offers electronic prescriptions in the addiction treatment space through BlockMD and wholesales supplements and superfoods under the Earth Circle Organics brand. Levitee Labs aims to integrate alternative and traditional medicine to address unmet needs in mental health and addiction treatment.
What They Do
- Operates integrative wellness clinics offering treatments for substance use disorders and chronic pain.
- Provides pharmaceutical services through its network of pharmacies.
- Offers electronic prescriptions for addiction treatment through the BlockMD platform.
- Wholesales supplements and superfoods under the Earth Circle Organics brand.
- Develops and offers evidence-based alternative medicines.
- Explores and develops novel psychedelic therapies for mental health conditions.
Business Model
- Generates revenue through medical services provided at its clinics.
- Earns revenue from the sale of pharmaceutical products at its pharmacies.
- Collects fees from electronic prescriptions through the BlockMD platform.
- Generates revenue from the wholesale of supplements and superfoods under the Earth Circle Organics brand.
Industry Context
Levitee Labs operates within the specialty and generic drug manufacturing industry, which is experiencing growth due to increasing demand for alternative and integrative therapies. The market for psychedelic therapies is nascent but rapidly expanding, driven by growing acceptance of their potential in treating mental health conditions. The competitive landscape includes companies like CNNXF, CSTF, GBHPF, INSO, and LTHO, which are involved in various aspects of healthcare and pharmaceutical services. Levitee Labs differentiates itself through its integrated approach, combining clinics, pharmacies, and digital platforms to provide comprehensive wellness solutions.
Key Customers
- Individuals seeking treatment for substance use disorders.
- Patients suffering from chronic pain conditions.
- Individuals seeking mental health support and alternative therapies.
- Pharmacies and retailers purchasing supplements and superfoods.
- Healthcare providers utilizing the BlockMD electronic prescription platform.
Financials
Chart & Info
Levitee Labs Inc. (LVTTF) stock price: Price data unavailable
Latest News
No recent news available for LVTTF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LVTTF.
Price Targets
Wall Street price target analysis for LVTTF.
MoonshotScore
What does this score mean?
The MoonshotScore rates LVTTF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: David Bentil
CEO
David Bentil serves as the CEO of Levitee Labs Inc., bringing a diverse background in business development and strategic leadership to the company. Prior to joining Levitee Labs, Bentil held various executive positions in the healthcare and technology sectors, where he focused on driving growth and innovation. His experience includes leading teams in product development, marketing, and sales, with a strong emphasis on building strategic partnerships and expanding market reach. Bentil holds a degree in Business Administration from a recognized university.
Track Record: Under David Bentil's leadership, Levitee Labs has focused on expanding its clinic network and developing its BlockMD electronic prescription platform. He has overseen the company's efforts to integrate alternative and traditional medicine, positioning Levitee Labs as a provider of comprehensive wellness solutions. Key milestones include the expansion of the Earth Circle Organics brand and the exploration of novel psychedelic therapies. Bentil's strategic decisions have aimed at driving revenue growth and establishing Levitee Labs as a leader in the emerging market for alternative and integrative healthcare.
LVTTF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Levitee Labs Inc. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Liquidity: Low trading volume can make it difficult to buy or sell shares.
- Information Scarcity: Lack of readily available financial information and disclosures.
- Regulatory Oversight: Reduced regulatory scrutiny compared to major exchanges.
- Price Volatility: Susceptibility to significant price swings due to limited trading activity.
- Going Concern Risk: Potential for financial instability or business failure.
- Verify the availability and accuracy of financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor trading volume and bid-ask spreads to assess liquidity.
- Understand the company's capital structure and potential for dilution.
- Consult with a financial advisor to assess the risks and suitability of the investment.
- Operations of clinics and pharmacies under established brands.
- Development of the BlockMD electronic prescription platform.
- Focus on evidence-based alternative medicines and therapies.
- Active management team with experience in the healthcare sector.
- Publicly traded status, even on the OTC market, indicating some level of transparency.
Common Questions About LVTTF
What does Levitee Labs Inc. do?
Levitee Labs Inc. operates as a multidisciplinary integrative wellness company, focusing on providing evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments: Medical Services and Selling Products. The Medical Services segment includes clinics offering treatments for substance use disorders, chronic pain, and mental health conditions. The Selling Products segment encompasses pharmacies and the wholesale of supplements and superfoods. Additionally, Levitee Labs offers electronic prescriptions through its BlockMD platform, aiming to provide comprehensive and accessible wellness solutions.
What do analysts say about LVTTF stock?
As of 2026-03-17, there is no readily available analyst consensus on LVTTF stock due to its OTC listing and limited coverage. Key valuation metrics include a negative P/E ratio of -0.03 and a profit margin of -662.4%, indicating current lack of profitability. However, the company's 39.9% gross margin suggests potential for improvement. Growth considerations include the expansion of its clinic network, the development of psychedelic therapies, and the growth of its BlockMD platform. Investors should conduct their own due diligence and consider the risks associated with OTC stocks.
What are the main risks for LVTTF?
The main risks for Levitee Labs Inc. include regulatory hurdles in the psychedelic therapy space, competition from established pharmaceutical companies and healthcare providers, and economic downturns affecting consumer spending on alternative therapies. Additionally, negative publicity or safety concerns related to psychedelic therapies could impact the company's reputation and growth prospects. As an OTC-listed stock, LVTTF also faces risks related to limited liquidity and potential price volatility. Investors should carefully consider these risks before investing in Levitee Labs Inc.
What are the key factors to evaluate for LVTTF?
Levitee Labs Inc. (LVTTF) currently holds an AI score of 47/100, indicating low score. Key strength: Integrated service model combining clinics, pharmacies, and digital platforms.. Primary risk to monitor: Potential: Regulatory hurdles and changing regulations in the psychedelic therapy space.. This is not financial advice.
How frequently does LVTTF data refresh on this page?
LVTTF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven LVTTF's recent stock price performance?
Recent price movement in Levitee Labs Inc. (LVTTF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Integrated service model combining clinics, pharmacies, and digital platforms.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider LVTTF overvalued or undervalued right now?
Determining whether Levitee Labs Inc. (LVTTF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying LVTTF?
Before investing in Levitee Labs Inc. (LVTTF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market investments carry higher risks than exchange-listed stocks.
- AI analysis pending for LVTTF.